CareLit · DOI-Nachweis · Pneumologie
Pharmacokinetic interactions in different combinations of specific pulmonary arterial hypertension treatment
DOI 10.1055/s-0036-1572031
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB Egenlauf, J Ohnesorge, N Benjamin, S Harutyunova, C Fischer, Y Enderle, J Burhenne, C Nagel, A Huppertz, A Carls, WE Haefeli, E Grünig
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Combination therapy of the phosphodiesterase-type 5 inhibitors (PDE-5I) sildenafil (SIL) or tadalafil (TAD) and endothelin receptor antagonists (ERA) bosentan (BOS), ambrisentan (AMB), or macitentan (MAC) may cause mutual interactions in patients with pulmonary arterial hypertension (PAH). Aim of this study was to compare plasma concentrations in PAH patients according to different combination treatmen…
Zitieren
Zitierempfehlung
B Egenlauf, J Ohnesorge, N Benjamin, S Harutyunova, C Fischer, Y Enderle, J Burhenne, C Nagel, A Huppertz, A Carls, WE Haefeli, E Grünig (2016) Pharmacokinetic interactions in different combinations of specific pulmonary arterial hypertension treatment. Pneumologie (02). https://doi.org/10.1055/s-0036-1572031
Mit CareLit weiterarbeiten